FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982148412> ?p ?o ?g. }

• W1982148412 endingPage "78" @default.
• W1982148412 startingPage "67" @default.
• W1982148412 abstract "Although the role of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway has been most extensively studied in hematopoietic cells and hematologic malignancies, it is also activated in epithelial tumors, including those originating in the lungs and head and neck. The canonical pathway involves the activation of JAK following ligand binding to cytokine receptors. The activated JAKs then phosphorylate STAT proteins, leading to their dimerization and translocation into the nucleus. In the nucleus, STATs act as transcription factors with pleiotropic downstream effects. STATs can be activated independently of JAKs, most notably by c-Src kinases. In cancer cells, STAT3 and STAT5 activation leads to the increased expression of downstream target genes, leading to increased cell proliferation, cell survival, angiogenesis, and immune system evasion. STAT3 and STAT5 are expressed and activated in head and neck squamous cell carcinoma (HNSCC) where they contribute to cell survival and proliferation. In HNSCC, STATs can be activated by a number of signal transduction pathways, including the epidermal growth factor receptor (EGFR), α7 nicotinic receptor, interleukin (IL) receptor, and erythropoietin receptor pathways. Activated STATs are also expressed in lung cancer, but the biological effects of JAK/STAT inhibition in this cancer are variable. In lung cancer, STAT3 can be activated by multiple pathways, including EGFR. Several approaches have been used to inhibit STAT3 in the hopes of developing an antitumor agent. Although several STAT3-specific agents are promising, none are in clinical development, mostly because of drug delivery and stability issues. In contrast, several JAK inhibitors are in clinical development. These orally available, ATP-competitive, small-molecule kinase inhibitors are being tested in myeloproliferative disorders. Future studies will determine whether JAK inhibitors are useful in the treatment of HNSCC or lung cancer." @default.
• W1982148412 created "2016-06-24" @default.
• W1982148412 creator A5022225065 @default.
• W1982148412 creator A5024203346 @default.
• W1982148412 date "2010-06-01" @default.
• W1982148412 modified "2023-10-18" @default.
• W1982148412 title "Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches" @default.
• W1982148412 cites W1225996684 @default.
• W1982148412 cites W1540079092 @default.
• W1982148412 cites W1548640328 @default.
• W1982148412 cites W1548791865 @default.
• W1982148412 cites W1619850371 @default.
• W1982148412 cites W1933735120 @default.
• W1982148412 cites W1943783753 @default.
• W1982148412 cites W1964691336 @default.
• W1982148412 cites W1965136295 @default.
• W1982148412 cites W1972718260 @default.
• W1982148412 cites W1977477483 @default.
• W1982148412 cites W1977568269 @default.
• W1982148412 cites W1981745443 @default.
• W1982148412 cites W1982317652 @default.
• W1982148412 cites W1982852897 @default.
• W1982148412 cites W1986396848 @default.
• W1982148412 cites W1990896527 @default.
• W1982148412 cites W1993059245 @default.
• W1982148412 cites W1995981641 @default.
• W1982148412 cites W1996612906 @default.
• W1982148412 cites W1997356417 @default.
• W1982148412 cites W2000707284 @default.
• W1982148412 cites W2001004826 @default.
• W1982148412 cites W2002189627 @default.
• W1982148412 cites W2004029306 @default.
• W1982148412 cites W2004695914 @default.
• W1982148412 cites W2007840001 @default.
• W1982148412 cites W2010326322 @default.
• W1982148412 cites W2011378064 @default.
• W1982148412 cites W2012307188 @default.
• W1982148412 cites W2015787839 @default.
• W1982148412 cites W2016116775 @default.
• W1982148412 cites W2016710415 @default.
• W1982148412 cites W2017715430 @default.
• W1982148412 cites W2020412873 @default.
• W1982148412 cites W2022200777 @default.
• W1982148412 cites W2022336314 @default.
• W1982148412 cites W2022956052 @default.
• W1982148412 cites W2025357617 @default.
• W1982148412 cites W2027253055 @default.
• W1982148412 cites W2027382240 @default.
• W1982148412 cites W2029478248 @default.
• W1982148412 cites W2029813057 @default.
• W1982148412 cites W2031793626 @default.
• W1982148412 cites W2032674547 @default.
• W1982148412 cites W2033485661 @default.
• W1982148412 cites W2034375425 @default.
• W1982148412 cites W2043696829 @default.
• W1982148412 cites W2044764720 @default.
• W1982148412 cites W2044991100 @default.
• W1982148412 cites W2045542032 @default.
• W1982148412 cites W2047536470 @default.
• W1982148412 cites W2047658647 @default.
• W1982148412 cites W2049817121 @default.
• W1982148412 cites W2052344543 @default.
• W1982148412 cites W2056165599 @default.
• W1982148412 cites W2058792197 @default.
• W1982148412 cites W2059287377 @default.
• W1982148412 cites W2061377922 @default.
• W1982148412 cites W2064621194 @default.
• W1982148412 cites W2069305322 @default.
• W1982148412 cites W2071693732 @default.
• W1982148412 cites W2071900493 @default.
• W1982148412 cites W2074356752 @default.
• W1982148412 cites W2074433596 @default.
• W1982148412 cites W2077356371 @default.
• W1982148412 cites W2078144380 @default.
• W1982148412 cites W2079870321 @default.
• W1982148412 cites W2082408605 @default.
• W1982148412 cites W2087032518 @default.
• W1982148412 cites W2090105988 @default.
• W1982148412 cites W2093696837 @default.
• W1982148412 cites W2093986699 @default.
• W1982148412 cites W2094455441 @default.
• W1982148412 cites W2094500359 @default.
• W1982148412 cites W2098223746 @default.
• W1982148412 cites W2098785500 @default.
• W1982148412 cites W2099805317 @default.
• W1982148412 cites W2101217991 @default.
• W1982148412 cites W2104668641 @default.
• W1982148412 cites W2110345092 @default.
• W1982148412 cites W2114375471 @default.
• W1982148412 cites W2114445658 @default.
• W1982148412 cites W2115533799 @default.
• W1982148412 cites W2116401711 @default.
• W1982148412 cites W2116628300 @default.
• W1982148412 cites W2117525838 @default.
• W1982148412 cites W2120392956 @default.
• W1982148412 cites W2123253654 @default.
• W1982148412 cites W2124254102 @default.
• W1982148412 cites W2125877707 @default.

• next